Welcome to the Working Group on New TB Drugs Blog
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part One
This is part one of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
Vienna 2010: Citizen News Service Correspondent Statement on IPT
Citizen News Service correspondent, Bobby Ramakant, reiterates the call from the Stop TB Working Group on TB/HIV to introduce Isoniazid prevention therapy to prevent the progression of latent TB infection to active disease. Effective IPT treatment reduces the development of active TB disease in 40-60% of patients. The content of this post originally appeared in an email sent to the Stop TB Health Dev mailing list.
WHO Releases Factsheet on Children and TB
Over 250,000 children develop TB and 100,000 children will continue to die each year from TB. A child usually gets TB infection from being exposed to a sputum-positive adult. Young children below ten years of age are at risk of becoming infected with TB bacilli. They are also at high risk of developing active tuberculosis because the immune system of young children is less developed.
The War on Tuberculosis – DOTS in Newark, NJ
Haile Meskel emerges from his Newark, New Jersey, row house and slips into the passenger seat of a shiny, late-model sedan, where a woman waits for him, a tiny white envelope and bottled water at the ready. He swallows a handful of pills as the woman watches. Within a couple of minutes the transaction is over. To the casual observer, this might look like one of the many furtive, illegal transactions that take place in this city every day—but it’s no drug deal. This is an example of directly observed therapy (DOT), which many public health and infectious disease experts believe is the single best method of treating people infected with tuberculosis and controlling the spread of multidrug-resistant and extensively drug-resistant strains in the United States and around the world.
Future of Olive View TB Ward in Doubt
Los Angeles County is spending more than $16 million to build a dedicated tuberculosis ward that also could serve as a treatment center to isolate victims of a bioterrorism attack. But something’s missing: people to staff it.
The Sanatorium Files Part One: Timeline
This post launches a new series on NewTBDrugs.org called “The Sanatorium Files,” which will explore how medical practitioners, caregivers, society and governments have fought the ongoing TB epidemic and the impact these treatments had and have on the patients receiving them. This first post in the series is a timeline showing the evolution of tuberculosis treatments, ranging from the harmless but useless to the painful, bizarre and dangerous, and ultimately leading to the antibiotics used to treat the disease for the last 30-40 years.
TB REACH announces US$ 18.4 million in grants for innovation in tuberculosis case finding
The Stop TB Partnership’s TB REACH initiative today announced the recipients of its first wave of grants to organizations that will engage in innovative approaches to increasing detection of tuberculosis (TB).
This Week in TB R&D – 04 May 2010
Over the last month, a few reports about new positive TB cases have surfaced from FL, involving a couple high schools and a college. Information was not made available as to how the original infected TB individuals contracted TB. Furthermore, it is not clear whether any of the newly identified TB positive individuals have developed active TB or latent TB (LTBI) since the diagnoses used the skin test, which only reveals exposure to TB.
Even LTBI treatment raises questions, however, particularly if it were to spread quickly through a close-knit population such as a high school.
New Vaccines Against Tuberculosis Needed for Prevention and Control
Only one vaccine against tuberculosis (TB) now exists, bacille Calmette Guérin (BCG), which confers incomplete protection against the disease. BCG has shown a certain amount of success against childhood TB meningitis and military TB, but it has shown little to no efficacy against adult pulmonary TB and even goes so far as to cause disease in HIV infected infants.
New Edition of WHO TB Treatment Guidelines
The World Health Organization’s Stop TB Department has published the fourth edition of Treatment of Tuberculosis: Guidelines. The guidelines contain a number of new recommendations, including a call to discontinue regimens based on just two months of rifampicin (2HRZE/6HE).
-
You are currently browsing the archives for the TB Prevention and Control Strategies category.
-
Toppix TB News- Expert says Tuberculosis a neglected disease 30 Jul 2010
- Potential Tuberculostatic Agents: Micelle-Forming Copolymer... 28 Jul 2010
- Center for Health Market Innovations: A Knowledge Database for BoP Markets 28 Jul 2010
- Study Identifies Effective, Inexpensive Test For Tuberculosis In Children 27 Jul 2010
- Randomized Trial in Haiti Shows Benefits of Early Antiretroviral Therapy 27 Jul 2010
